The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States.

Please find the current information about these vaccines and some other relevant information for our patients.

In the face of the challenges posed by the current COVID-19 pandemic, LDRTC is continuing to serve the Rare Disease community by maintaining the medical services offered to our patients with Lysosomal Disorders, Immune deficiencies, and other rare diseases.

We remain fully operational to administer infusions and injectable therapies at our Infusion Clinic. Clinical Trial protocols for many life-saving therapies are similarly moving forward without any interruption.

Dear patients and family members,

With the emergence of COVID-19 pandemic, our patients and their families are understandably unsettled about its implications for their health and well-being.

We suggest that the patients under our care follow the CDC recommendations given to the highest risk populations such as the elderly and those with other co-morbid conditions, which pose a greater risk of complications. Please check the CDC website for current updates.